A New Enzyme to Inhibit LRRK2

A New Enzyme to Inhibit LRRK2
Researchers in Dundee (Scotland) and Stanford (USA) have identified a novel method of reducing LRRK2 activity in Parkinson's. Mutations in the gene that codes for the leucine-rich repeat kinase 2 or the LRRK2 gene are a major cause of familial and sporadic (non-familial) Parkinson's. LRRK2 is a complex protein, a part of which acts as an enzyme catalyst and interacts ... read more
Source: The Cure Parkinson’s TrustPublished on 2019-11-05